Surgery Partners, Inc. (NASDAQ:SGRY), a prominent player in the healthcare services sector with a market capitalization of $3.26 billion, has been making waves in the market with its focus on surgical ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 41.82% ...

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Liquidia Technologies (LQDA – Research Report), with a ...